DOI QR코드

DOI QR Code

Clinicopathologic Features and Outcomes of Endoscopic Submucosal Dissection for Foveolar-Type Adenocarcinoma of the Stomach

  • Minjee Kim (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Tae-Se Kim (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Byung-Hoon Min (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yang Won Min (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Hyuk Lee (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jun Haeng Lee (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Poong-Lyul Rhee (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jae J. Kim (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kyoung-Mee Kim (Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 투고 : 2024.05.03
  • 심사 : 2024.07.09
  • 발행 : 2024.10.01

초록

Purpose: Foveolar-type adenocarcinoma of the stomach is a rare variant of gastric cancer. The clinicopathological features and outcomes of endoscopic submucosal dissection (ESD) for gastric foveolar-type adenocarcinoma remain unclear. Materials and Methods: This study included 1,161 patients who underwent ESD for single early gastric cancers (EGCs) (78 foveolar-type adenocarcinomas and 1,083 well-differentiated [WD] adenocarcinomas). The clinicopathological features and short- and long-term outcomes of ESD for gastric foveolar-type adenocarcinomas were reviewed and compared with those for WD EGCs. Results: Gastric foveolar-type adenocarcinomas were larger and more likely to exhibit an elevated macroscopic appearance than WD EGCs. Foveolar-type adenocarcinomas exhibited higher rates of lymphatic invasion, histological heterogeneity, and lateral margin involvement than WD EGCs. The en bloc R0 and curative resection rates of foveolar-type adenocarcinoma were 85.9% and 76.9%, respectively. Both foveolar-type adenocarcinoma rates were significantly lower than those of WD EGCs (95.8% and 91.3%, respectively). Lateral margin involvement accounted for 55.6% of the non-curative resection cases of foveolar-type adenocarcinoma. Among patients who underwent curative ESD for foveolar-type adenocarcinoma, no recurrence occurred during the median 62.3 months of follow-up. No lymph node metastases were detected in patients with foveolar-type adenocarcinoma who underwent additional surgery following ESD. The overall and disease-specific survival rates of patients with foveolar-type adenocarcinoma were comparable to those of patients with WD EGC. Conclusions: Gastric foveolar-type adenocarcinomas have distinct clinicopathological features among WD EGCs. Given favorable long-term outcomes after curative resection, ESD can be indicated for early gastric foveolar-type adenocarcinomas.

키워드

과제정보

We thank Professor Ryoji Kushima (Department of Pathology, Shiga University of Medical Science, Otsu, Shiga, Japan) for his valuable comments on the pathological diagnosis of the cases included in the present study.

참고문헌

  1. Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K, Hattori T. Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer 2006;9:177-184.
  2. Abe H, Ushiku T. Pathological diversity of gastric cancer from the viewpoint of background condition. Digestion 2022;103:45-53.
  3. Kushima R. The updated WHO classification of digestive system tumours-gastric adenocarcinoma and dysplasia. Pathologe 2022;43:8-15.
  4. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011;14:101-112.
  5. Sekine S, Yoshida H, Jansen M, Kushima R. The Japanese viewpoint on the histopathology of early gastric cancer. Adv Exp Med Biol 2016;908:331-346.
  6. Sugai T, Uesugi N, Habano W, Sugimoto R, Eizuka M, Fujita Y, et al. The clinicopathological and molecular features of sporadic gastric foveolar type neoplasia. Virchows Arch 2020;477:835-844.
  7. Shibagaki K, Ishimura N, Kotani S, Fukuyama C, Takahashi Y, Kishimoto K, et al. Endoscopic differential diagnosis between foveolar-type gastric adenoma and gastric hyperplastic polyps in Helicobacter pylorinaive patients. Gastric Cancer 2023;26:1002-1011. 
  8. Min BH, Kim KM, Park CK, Lee JH, Rhee PL, Rhee JC, et al. Outcomes of endoscopic submucosal dissection for differentiated-type early gastric cancer with histological heterogeneity. Gastric Cancer 2015;18:618-626.
  9. Kim TS, Kim B, Min BH, Min YW, Lee H, Lee JH, et al. Outcomes of endoscopic submucosal dissection for intestinal-type adenocarcinoma with anastomosing glands of the stomach. J Gastroenterol Hepatol 2020;35:50-55.
  10. Min BH, Kim ER, Kim KM, Park CK, Lee JH, Rhee PL, et al. Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer. Endoscopy 2015;47:784-793.
  11. Pyo JH, Lee H, Min BH, Lee JH, Choi MG, Lee JH, et al. Long-term outcome of endoscopic resection vs. surgery for early gastric cancer: a non-inferiority-matched cohort study. Am J Gastroenterol 2016;111:240-249.
  12. Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer 2023;26:1-25.
  13. Park YS, Kook MC, Kim BH, Lee HS, Kang DW, Gu MJ, et al. A Standardized Pathology Report for Gastric Cancer: 2nd edition. J Gastric Cancer 2023;23:107-145.
  14. Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, et al. Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer 2023;23:3-106.
  15. Naka T, Hashimoto T, Cho H, Tanabe N, Yoshida T, Yatabe Y, et al. Sporadic and familial adenomatous polyposis-associated foveolar-type adenoma of the stomach. Am J Surg Pathol 2023;47:91-101.
  16. Mishiro T, Shibagaki K, Fukuyama C, Kataoka M, Notsu T, Yamashita N, et al. KLF4 mutation shapes pathologic characteristics of foveolar-type gastric adenoma in Helicobacter pylori-naive patients. Am J Pathol 2022;192:1250-1258.
  17. Shibagaki K, Fukuyama C, Mikami H, Izumi D, Yamashita N, Mishiro T, et al. Gastric foveolar-type adenomas endoscopically showing a raspberry-like appearance in the Helicobacter pylori -uninfected stomach. Endosc Int Open 2019;7:E784-E791.
  18. Shibagaki K, Mishiro T, Fukuyama C, Takahashi Y, Itawaki A, Nonomura S, et al. Sporadic foveolar-type gastric adenoma with a raspberry-like appearance in Helicobacter pylori-naive patients. Virchows Arch 2021;479:687-695.